^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
GZ402663
i
Other names: GZ402663, sFLT01, anti vascular endothelial growth factor (VEGF) gene therapy, AAV2sFLT 01, AAV2-sFLT01, GZ-402663
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Beacon Therapeutics, Sanofi
Drug class:
VEGF-A inhibitor, Gene transference, PIGF inhibitor
Related drugs:
